ProfileOfResearchers

TITLE: Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial Full Text
AUTHORS: Knop, S; Mateos, MV; Dimopoulos, MA; Suzuki, K; Jakubowiak, A; Doyen, C; Lucio, P; Nagy, Z; Usenko, G; Pour, L; Cook, M; Grosicki, S; Crepaldi, A; Liberati, AM; Campbell, P; Shelekhova, T; Yoon, SS; Losava, G; Fujisaki, T; Garg, M; Wang, JP; Wroblewski, S; Kudva, A; Gries, KS; Fastenau, J; San Miguel, J; Cavo, M; ...More
PUBLISHED: 2021, SOURCE: BMC CANCER, VOLUME: 21, ISSUE: 1

INDEXED IN:

Scopus

WOS

TITLE: Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial Full Text
AUTHORS: Maria Victoria Mateos; Michele Cavo; Joan Blade; Meletios A Dimopoulos; Kenshi Suzuki; Andrzej Jakubowiak; Stefan Knop; Chantal Doyen; Paulo Lucio; Zsolt Nagy; Ludek Pour; Mark Cook; Sebastian Grosicki; Andre Crepaldi; Anna Marina Liberati; Philip Campbell; Tatiana Shelekhova; Sung Soo Yoon; Genadi Iosava; Tomoaki Fujisaki; Mamta Garg; Maria Krevvata; Ying Chen; Jianping P Wang; Anupa Kudva; Jon Ukropec; Susan Wroblewski; Ming Qi; Rachel Kobos; Jesus San Miguel; ...More
PUBLISHED: 2020, SOURCE: LANCET, VOLUME: 395, ISSUE: 10218

INDEXED IN:

WOS

TITLE: Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
AUTHORS: Mateos, MV; Dimopoulos, MA; Cavo, M; Suzuki, K; Jakubowiak, A; Knop, S; Doyen, C; Lucio, P; Nagy, Z; Kaplan, P; Pour, L; Cook, M; Grosicki, S; Crepaldi, A; Liberati, AM; Campbell, P; Shelekhova, T; Yoon, SS; Iosava, G; Fujisaki, T; Garg, M; Chiu, C; Wang, J; Carson, R; Crist, W; Deraedt, W; Nguyen, H; Qi, M; San Miguel, J; ...More
PUBLISHED: 2018, SOURCE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 378, ISSUE: 6

INDEXED IN:

Scopus

WOS

Useful Links